‘Champix’ extended in usage by gradual smoking cessation

Published: 2017-06-23 16:27:00
Updated: 2017-06-23 15:47:17

On the 12th, Champix(generic name: varenicline tartrate), a Pfizer Pharmaceuticals Korea’s(CEO/President Dong-Wook Oh) supportive therapy of quitting smoking, was approved from the Ministry of Food and Drug Safety for extension of usage and volume in terms of smoking cessation by phase. The resul...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.